Compare RDVT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDVT | OPK |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.0M | 1.0B |
| IPO Year | 2017 | 2011 |
| Metric | RDVT | OPK |
|---|---|---|
| Price | $78.20 | $1.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $62.00 | $1.60 |
| AVG Volume (30 Days) | 187.8K | ★ 2.5M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.00 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | $90,252,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $16.31 | N/A |
| Revenue Next Year | $13.83 | $4.24 |
| P/E Ratio | $121.63 | ★ N/A |
| Revenue Growth | ★ 20.03 | N/A |
| 52 Week Low | $33.40 | $0.98 |
| 52 Week High | $80.29 | $1.75 |
| Indicator | RDVT | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 60.07 | 58.46 |
| Support Level | $66.35 | $1.12 |
| Resistance Level | $80.29 | $1.73 |
| Average True Range (ATR) | 2.53 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 72.58 | 66.07 |
Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.